Pluristyx Revenue and Competitors
Estimated Revenue & Valuation
- Pluristyx's estimated annual revenue is currently $3.1M per year.
- Pluristyx's estimated revenue per employee is $155,000
Employee Data
- Pluristyx has 20 Employees.
- Pluristyx grew their employee count by -39% last year.
Pluristyx's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | Chief Operating Officer and Co-Founder | Reveal Email/Phone |
3 | Chief Technology Officer | Reveal Email/Phone |
4 | Director, Head Process and Analytical Development | Reveal Email/Phone |
5 | Director, Process Engineering & Operations | Reveal Email/Phone |
6 | Applications Scientist & Technical Project Manager | Reveal Email/Phone |
7 | Research Associate | Reveal Email/Phone |
8 | General Counsel | Reveal Email/Phone |
9 | Research Engineer III | Reveal Email/Phone |
Pluristyx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $3.3M | 43 | 10% | $101M | N/A |
#4 | $5.7M | 37 | 12% | N/A | N/A |
#5 | $7M | 45 | 41% | N/A | N/A |
#6 | $1.7M | 22 | -8% | N/A | N/A |
#7 | $3.9M | 50 | 4% | $10.1M | N/A |
#8 | $1.9M | 12 | -73% | N/A | N/A |
#9 | $29.3M | 151 | -17% | $148M | N/A |
#10 | $2M | 13 | 86% | N/A | N/A |
What Is Pluristyx?
Pluristyx, Inc. is an advanced therapy tools and service company serving customers in the rapidly growing field of regenerative medicine and cellular therapies. Pluristyx has a line of pluripotent stem cell based products and also offers contract development, manufacturing, and consulting services.
keywords:N/AN/A
Total Funding
20
Number of Employees
$3.1M
Revenue (est)
-39%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 20 | N/A | N/A |
#2 | $2M | 20 | -17% | $95.3M |
#3 | $3.5M | 20 | -9% | N/A |
#4 | $3.4M | 20 | -5% | N/A |
#5 | $3.1M | 20 | -9% | N/A |